Association of Matrix Metalloproteinase-1 Promoter Polymorphisms With Asthma Risk
In Vivo · 2024
DOI: 10.21873/invivo.13447 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Li-Hsiou Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Chest Medicine, Department of Internal Medicine, Taichung Tzu Chi Hospital, Taichung, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Asthma, Matrix Metalloproteinase 1. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/AIM: Matrix metalloproteinase-1 (MMP-1) expression has been documented as an influential contributor to the intricate milieu of allergic airway inflammation, tissue remodeling, and the exacerbation of asthma's severity. However, the genetic role underlying MMP-1 in the context of asthma has remained enigmatic, with its full implications yet to be unveiled. Considering this, our research was designed to investigate the association of MMP-1 -1607 rs1799750 and the propensity for asthma severity. PATIENTS AND METHODS: As a case-control investigation, our study enrolled 198 individuals diagnosed with asthma and age- and sex-matched 453 non-asthmatic controls. The genotypes of MMP-1 rs1799750 were determined utilizing the polymerase chain reaction-restriction fragment length polymorphism methodology. RESULTS: The frequency distributions of 2G/2G, 1G/2G and 1G/1G genotypes at MMP-1 rs1799750 were 49, 42.9, and 8.1%, respectively, among the patients with asthma. This pattern was not different from that of controls (43.7, 46.8, and 9.5%, respectively) (p for trend=0.4486). The allelic frequency pertaining to the variant 1G allele within the asthma group was 29.5%, with a non-significant disparity compared to the 32.9% in the control group (p=0.2596). Noticeably, there was a positive association between MMP-1 rs1799750 2G/1G and 1G/1G genotypes with asthma severity (p=0.0060). CONCLUSION: Our research indicated that the presence of MMP-1 rs1799750 1G allele might not be the sole arbiter of an individual's susceptibility to asthma, yet its potential to function as a discerning prognostic marker for the severity of asthma emerged as a noteworthy finding deserving attention and further exploration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Chest Medicine, Department of Internal Medicine, Taichung Tzu Chi Hospital, Taichung, Taiwan, R.O.C.
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
- Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan, R.O.C.
- Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.
- National Defense Medical Center, Taipei, Taiwan, R.O.C.
Zitieren
APA
Chen, L. H., Li, C. H., Wang, S. C., Chiu, K. L., Wu, M. F., Yang, J. S., Tsai, C. W., Chang, W. S., Hsia, T. C., & Bau, D. T. (2024). Association of Matrix Metalloproteinase-1 Promoter Polymorphisms With Asthma Risk. In Vivo. https://doi.org/10.21873/invivo.13447
Vancouver
Chen LH, Li CH, Wang SC, Chiu KL, Wu MF, Yang JS, et al. Association of Matrix Metalloproteinase-1 Promoter Polymorphisms With Asthma Risk. In Vivo. 2024. doi:10.21873/invivo.13447
BibTeX
@article{Chen2024,
author = {Chen, Li-Hsiou and Li, Chia-Hsiang and Wang, Shou-Cheng and Chiu, Kuo-Liang and Wu, Meng-Feng and Yang, Jai-Sing and Tsai, Chia-Wen and Chang, Wen-Shin and Hsia, Te-Chun and Bau, DA-Tian},
title = {Association of Matrix Metalloproteinase-1 Promoter Polymorphisms With Asthma Risk},
journal = {In Vivo},
year = {2024},
doi = {10.21873/invivo.13447}
}
EUVIMED